Steven W Lamberts

Title: The Innovations of Steven W. Lamberts

Introduction

Steven W. Lamberts is a notable inventor based in Rotterdam, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of somatostatin peptides. With a total of 3 patents to his name, Lamberts continues to push the boundaries of medical science.

Latest Patents

One of Lamberts' latest patents is focused on the therapeutic use of somatostatin peptides. This invention relates to a new pharmaceutical application of somatostatin peptides that include a polyamino polycarboxylic group on the terminal amino group. This innovation is particularly relevant in the manufacture of a medicament for treating disorders associated with excess growth hormone secretion. Another significant patent involves chelated somatostatin peptides and their complexes. These peptides bear at least one chelating group for a detectable element, which is linked to an amino group of the peptide. This invention is useful as a radiopharmaceutical for in vivo imaging of somatostatin receptor-positive tumors or for therapeutic applications.

Career Highlights

Lamberts has had a distinguished career, working with leading pharmaceutical companies. He is currently associated with Novartis AG, where he continues to innovate and develop new therapeutic solutions. His work has had a profound impact on the treatment of various medical conditions.

Collaborations

Throughout his career, Lamberts has collaborated with esteemed colleagues, including Eric Paul Krenning and Rainer Albert. These collaborations have further enhanced his research and development efforts in the pharmaceutical field.

Conclusion

Steven W. Lamberts is a pioneering inventor whose work in somatostatin peptides has the potential to transform medical treatments. His contributions to the pharmaceutical industry are invaluable, and his ongoing research promises to yield further advancements in healthcare.